Navrogen
Finding cures with you in mind
United States
4 employees
Seed
Total: $6.20M
Biotechnology, Life Sciences +1
General Information
United States
BounceWatch is an independent company data service, not affiliated with Navrogen. To contact Navrogen, visit navrogen.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Navrogen compare?
A PDF of Navrogen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Navrogen soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Navrogen on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Navrogen
Business keywords: biopharmaceuticals, targeted therapies, oncology, immuno oncology, cancer treatment, immune system modulation
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | $3.00M | 1 |
|
09 Aug 2021 |
| Convertible Note | $3.20M | 1 |
|
17 Sep 2019 |
Navrogen Alternatives & Competitors
View All Alternatives
Developing novel therapies for treatment of the most aggressive cancers by acting on the tumor micro...
Targeting cancer, differently.
We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...
FAQ About Navrogen
Source: BounceWatch company record for Navrogen, https://bouncewatch.com/company/navrogen, updated 10 October 2024. When citing, please name BounceWatch and link this page.
